Product Information
PRAMIPEXOLE 0.125 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0465 per EA under NDC 33342003115. Its NADAC has been published 505 times since Sep 16, 2015.
FDA first approved this application on Sep 20, 2012.
Strength
.125 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342003115
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
PRAMIPEXOLE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202164FDA Approved
9/20/2012
On Market Since
9/21/2012
Pharmacological Classes
Price Statistics
The NADAC for PRAMIPEXOLE 0.125 MG TABLET has been published 505 times since Sep 16, 2015, and over the history we have for it it has declined 36.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0465 per EA |
|---|---|
| All-time high | $0.0786 (Jun 15, 2016) |
| All-time low | $0.0350 (Nov 20, 2024) |
| Median price | $0.0520 |
| Average price | $0.0545 |
| Largest weekly change | +31.1% (Dec 23, 2015) |
| Weeks tracked | 505 |
| Tracking since | Sep 16, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+2.4%
5Y
-7.9%
All
-36.9%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pramipexole dihydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonergot Dopamine Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PRAMIPEXOLE 0.125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PRAMIPEXOLE 0.125 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.0465 per EA (NDC 33342003115), effective May 14, 2025.
How has the price of PRAMIPEXOLE 0.125 MG TABLET changed over time?
Over the history we have for it, the NADAC for PRAMIPEXOLE 0.125 MG TABLET has declined 36.9%. It has been tracked across 505 weekly CMS publications since Sep 16, 2015.
What are the highest and lowest recorded NADAC prices for PRAMIPEXOLE 0.125 MG TABLET?
Since Sep 16, 2015, the NADAC for PRAMIPEXOLE 0.125 MG TABLET has ranged from a low of $0.0350 (Nov 20, 2024) to a high of $0.0786 (Jun 15, 2016), with a median of $0.0520 per EA.
Are there cheaper alternatives to PRAMIPEXOLE 0.125 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PRAMIPEXOLE 0.125 MG TABLET, is $0.0394 per EA — about 15% below PRAMIPEXOLE 0.125 MG TABLET.
Who manufactures PRAMIPEXOLE 0.125 MG TABLET?
PRAMIPEXOLE 0.125 MG TABLET (NDC 33342003115) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.